Trial Profile
Biphasic Insulin Aspart 70/30 + Metformin Compared to Insulin Glargine + Metformin in Type 2 Diabetes Failing OAD Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INITIATE
- Sponsors Novo Nordisk
- 13 May 2015 New trial record